Lai Chan, PhD

Synthetic lethality as a therapeutic strategy for diffuse large B-cell lymphoma

We propose a new DLBCL treatment using a concept called synthetic lethality. Synthetic lethality happens when changes in two genes cause cells to die, but a change in either gene alone does not. This approach selectively targets DLBCL with specific changes in specific genes, making it a promising treatment option.